Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma

NCT00017134 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT00017134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00017134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Evaluation of Fenretinide (4-HPR) as a Chemopreventive Agent for Ovarian Carcinoma
Lead sponsor
Gynecologic Oncology Group
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2002
Completion date
Not reported
Enrollment
71 (estimated)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer